報價延遲最少15分鐘:2025/07/04 19:30 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
15.34 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
33.62/106.02
|
|
企業價值
4,014.49B
|
| 資產負債 |
|
每股賬面淨值
15.36
|
| 現金流量 |
|
現金流量率
0.15
|
| 損益表 |
|
收益
4,581.55B
|
|
每股收益
8.90
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/07/04 19:30 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada. |